PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22045191-7	2012	The EMT transcription factor, ZEB1, shows altered expression in erlotinib-sensitive NSCLC and PDAC, where many signature miRNA genes are upregulated.	Erlotinib Hydrochloride	64-73	zinc finger E-box binding homeobox 1	Homo sapiens	30-34	
24911146-8	2014	While miR-205 depletion induced erlotinib resistance, miR-205 overexpression inhibited CRIPTO1-dependent ZEB1 and SRC activation, restoring erlotinib sensitivity.	Erlotinib Hydrochloride	140-149	zinc finger E-box binding homeobox 1	Homo sapiens	105-109	
19147758-0	2009	Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines.	Erlotinib Hydrochloride	168-177	zinc finger E-box binding homeobox 1	Homo sapiens	0-42	
19147758-7	2009	In contrast, the erlotinib-resistant HNSCC lines expressed high levels of the E-cadherin repressor delta-crystallin enhancer binding factor 1 (deltaEF1; Zeb-1) and other mesenchymal markers and low levels of E-cadherin, and they were highly invasive and migratory.	Erlotinib Hydrochloride	17-26	zinc finger E-box binding homeobox 1	Homo sapiens	99-141	
19147758-7	2009	In contrast, the erlotinib-resistant HNSCC lines expressed high levels of the E-cadherin repressor delta-crystallin enhancer binding factor 1 (deltaEF1; Zeb-1) and other mesenchymal markers and low levels of E-cadherin, and they were highly invasive and migratory.	Erlotinib Hydrochloride	17-26	zinc finger E-box binding homeobox 1	Homo sapiens	143-151	
19147758-7	2009	In contrast, the erlotinib-resistant HNSCC lines expressed high levels of the E-cadherin repressor delta-crystallin enhancer binding factor 1 (deltaEF1; Zeb-1) and other mesenchymal markers and low levels of E-cadherin, and they were highly invasive and migratory.	Erlotinib Hydrochloride	17-26	zinc finger E-box binding homeobox 1	Homo sapiens	153-158	
19147758-8	2009	Small interfering RNA-mediated knockdown of deltaEF1 in the erlotinib-resistant cell lines (1386LN and UMSCC1) resulted in up-regulation of E-cadherin and increased sensitivity to erlotinib in an E-cadherin-dependent manner.	Erlotinib Hydrochloride	60-69	zinc finger E-box binding homeobox 1	Homo sapiens	44-52	
19147758-8	2009	Small interfering RNA-mediated knockdown of deltaEF1 in the erlotinib-resistant cell lines (1386LN and UMSCC1) resulted in up-regulation of E-cadherin and increased sensitivity to erlotinib in an E-cadherin-dependent manner.	Erlotinib Hydrochloride	180-189	zinc finger E-box binding homeobox 1	Homo sapiens	44-52	
19147758-9	2009	CONCLUSIONS: DeltaEF1 controls the mesenchymal phenotype and drives erlotinib resistance in HNSCC cells.	Erlotinib Hydrochloride	68-77	zinc finger E-box binding homeobox 1	Homo sapiens	13-21	
26789630-9	2016	Short-interfering RNA against ZEB1 reversed the EMT phenotype and, importantly, restored erlotinib sensitivity in HCC4006ER cells.	Erlotinib Hydrochloride	89-98	zinc finger E-box binding homeobox 1	Homo sapiens	30-34